Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Low dose ketamine can interact with medicines that change ketamine metabolism or add to sedation, blood-pressure changes, or cognitive effects. The highest-priority review is usually for benzodiazepines, opioids, alcohol use, stimulants, MAOIs, and medicines that strongly inhibit or induce CYP3A4 or CYP2B6. Do not stop, skip, or change a prescribed medicine on your own. A clinician who knows your full medication list should decide whether treatment timing, dose, or monitoring needs to change.
Ketamine interaction evidence is uneven. Some findings come from pharmacology studies, anesthesia practice, small clinical studies, or case reports rather than large studies of low-dose psychiatric treatment. That makes a careful medication review more useful than a one-size-fits-all hold schedule.
Quick Answer
Low dose ketamine requires extra caution with central nervous system depressants, stimulants, MAOIs, and drugs that strongly alter CYP3A4 or CYP2B6 activity. Bring every prescription, over-the-counter medicine, supplement, and substance-use detail to the prescribing clinician, including occasional alcohol, cannabis, and grapefruit products. The safest next step is an individualized review before each treatment.
Why medication interactions matter with ketamine
Pharmacokinetic interactions change how much ketamine or its metabolites circulate in the body. Ketamine is metabolized in part through CYP3A4 and CYP2B6, so strong enzyme inhibitors may increase exposure and strong inducers may reduce it. Pharmacodynamic interactions occur when another substance adds to ketamine's effects on alertness, breathing, blood pressure, heart rate, or cognition.
According to a review of ketamine drug interactions, ketoconazole co-administration increased ketamine exposure by about 45% in a pharmacokinetic study, although the practical effect can differ by dose, route, and patient factors. Read the review in PubMed's ketamine interaction review.
For a broader overview of treatment safety questions, see monitoring and assessment and common ketamine side effects.
Important
Alcohol, opioids, benzodiazepines, sleep medicines, and muscle relaxants can all add to sedation and impairment. Avoid driving or operating machinery after treatment until your treating team says you have recovered and you can safely do so.
Interactions that deserve a focused review
CNS depressants: benzodiazepines, opioids, alcohol, and sedating medicines
These substances can add to sleepiness, slowed reaction time, dizziness, and impaired coordination. Opioids and benzodiazepines deserve particular attention because the combination may require closer observation for sedation and breathing effects. The U.S. prescribing information for esketamine nasal spray warns that concomitant CNS depressants may increase sedation and advises close monitoring. See the current DailyMed prescribing information for SPRAVATO.
Research on benzodiazepines and ketamine's antidepressant response is mixed and limited. Some observational research has reported lower response among people taking higher benzodiazepine doses, but this does not establish that every patient should hold a benzodiazepine. Abrupt changes can cause withdrawal or rebound anxiety. The prescriber should weigh those risks against treatment-day sedation and treatment goals. See also ketamine and benzodiazepines and ketamine and alcohol safety risks.
Medicines that affect CYP3A4 or CYP2B6
Strong CYP3A4 inhibitors, including some azole antifungals, macrolide antibiotics, and HIV treatment regimens, may slow ketamine metabolism. Strong inducers, such as rifampin and some antiseizure medicines, may lower ketamine exposure. Grapefruit can inhibit intestinal CYP3A4 and is most relevant to oral ketamine because it may change first-pass metabolism.
These categories are not instructions to alter treatment yourself. The clinician needs the exact medicine, dose, route, timing, liver function, and ketamine formulation to judge whether a meaningful interaction is likely. Supplements matter too. St. John's wort is a known enzyme inducer and should be included in the medication review.
Stimulants and blood-pressure medicines
Ketamine can temporarily increase blood pressure and heart rate. Prescription stimulants, cocaine, methamphetamine, decongestants, and other sympathomimetic substances may add to that effect. Recent non-prescribed stimulant use should be disclosed before treatment because it can change the safety assessment.
Do not assume that an antihypertensive medicine should be skipped or added for ketamine. Blood-pressure management depends on the individual's baseline readings, cardiac history, and prescribed regimen. Our guide to cardiovascular monitoring explains why treatment settings track blood pressure before, during, and after dosing.
Serotonergic medicines and MAOIs
SSRIs and SNRIs are common among people considering ketamine. Reports of serotonin toxicity with ketamine in this setting are uncommon, but the treating team should review the full serotonergic medication load and watch for symptoms such as agitation, sweating, tremor, clonus, fever, or confusion.
MAOIs need a more individualized plan because they can amplify catecholamine and serotonin-related effects. Published guidance and case literature are limited, and the appropriate approach depends on the specific MAOI and clinical situation. A patient taking an MAOI should not make a washout decision without coordination between the ketamine prescriber and the clinician managing the MAOI.
Lithium, lamotrigine, and anticholinergic medicines
Lithium has no established major pharmacokinetic interaction with ketamine, but routine lithium safety monitoring still applies. Vomiting, poor fluid intake, or dehydration can affect lithium handling. Lamotrigine may reduce some ketamine-related perceptual effects in experimental settings, but whether it changes therapeutic benefit remains unclear.
Medicines with anticholinergic effects, such as some tricyclic antidepressants, bladder medicines, and antihistamines, may add to dry mouth, blurred vision, urinary retention, confusion, or tachycardia. This is especially relevant for older adults and people taking several anticholinergic medicines.
Compare low-dose options
Review routes, dosing discussions, and alternatives before speaking with a clinician.
Compare optionsWhat to bring to a ketamine medication review
- A complete list of prescriptions, doses, and the time each medicine is taken.
- Over-the-counter products, including antihistamines, cough and cold medicines, and sleep aids.
- Supplements and herbal products, especially St. John's wort and grapefruit-containing products.
- Recent alcohol, cannabis, opioid, stimulant, or other substance use.
- Any prior severe sedation, high blood pressure, fainting, or unusual reaction during treatment.
How clinicians can make the interaction review practical
A useful review identifies the medicine, the likely mechanism, the consequence to watch for, and the monitoring plan. It should also distinguish a theoretical interaction from one with direct clinical evidence.
Ask these questions before treatment:
- Could this medicine increase sedation, breathing risk, confusion, or falls?
- Could it raise blood pressure or heart rate during treatment?
- Is it a strong CYP3A4 or CYP2B6 inhibitor or inducer?
- Would holding or changing it create withdrawal, relapse, seizure, pain, or blood-pressure risk?
- What symptoms should prompt a call to the treatment team or urgent medical care?
Monitoring may include blood-pressure checks, assessment of alertness and coordination, and longer observation when sedating medicines or significant medical risks are present. The treatment setting and route matter. Findings from intravenous ketamine or anesthesia may not translate directly to oral, sublingual, or intranasal treatment.
For questions about spacing and recovery between sessions, read how far apart low-dose ketamine treatments should be spaced.
Key Takeaway
The most important safety tool is an accurate, current medication and substance-use list. A possible interaction does not always rule out low-dose ketamine, but it can change the treatment plan and monitoring needed.
Review More Safety Questions
Read practical safety guidance to prepare for a well-informed discussion with your treating clinician.
Frequently Asked Questions
Do not stop an antidepressant unless the clinician who prescribes it tells you to. SSRIs and SNRIs are often continued, while MAOIs and combinations involving several serotonergic medicines require a more individualized review.
Alcohol can add to ketamine-related sedation and impairment. Tell the treatment team about recent alcohol use and follow its treatment-day instructions.
Some supplements can affect drug-metabolizing enzymes or add to sedation. St. John's wort and grapefruit products are examples worth reporting during a medication review.
Seek urgent medical help for trouble breathing, chest pain, fainting, severe confusion, or symptoms that suggest a severe allergic or neurologic reaction. Contact the treating team promptly for persistent or concerning sedation, blood-pressure symptoms, or vomiting.
Share
Related Reading
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.